Literature DB >> 29550768

Cryo-EM structure of a mammalian RNA polymerase II elongation complex inhibited by α-amanitin.

Xiangyang Liu1, Lucas Farnung1, Christoph Wigge1, Patrick Cramer2.   

Abstract

RNA polymerase II (Pol II) is the central enzyme that transcribes eukaryotic protein-coding genes to produce mRNA. The mushroom toxin α-amanitin binds Pol II and inhibits transcription at the step of RNA chain elongation. Pol II from yeast binds α-amanitin with micromolar affinity, whereas metazoan Pol II enzymes exhibit nanomolar affinities. Here, we present the high-resolution cryo-EM structure of α-amanitin bound to and inhibited by its natural target, the mammalian Pol II elongation complex. The structure revealed that the toxin is located in a pocket previously identified in yeast Pol II but forms additional contacts with metazoan-specific residues, which explains why its affinity to mammalian Pol II is ∼3000 times higher than for yeast Pol II. Our work provides the structural basis for the inhibition of mammalian Pol II by the natural toxin α-amanitin and highlights that cryo-EM is well suited to studying interactions of a small molecule with its macromolecular target.
© 2018 Liu et al.

Entities:  

Keywords:  RNA polymerase; RNA polymerase II; cryo-electron microscopy; structural biology; transcription

Mesh:

Substances:

Year:  2018        PMID: 29550768      PMCID: PMC5949985          DOI: 10.1074/jbc.RA118.002545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  A Mediator-responsive form of metazoan RNA polymerase II.

Authors:  Xiaopeng Hu; Sohail Malik; Costin Catalin Negroiu; Kyle Hubbard; Chidambaram Natesa Velalar; Brian Hampton; Dan Grosu; Jennifer Catalano; Robert G Roeder; Averell Gnatt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

Review 2.  Fifty years of amanitin.

Authors:  T Wieland; H Faulstich
Journal:  Experientia       Date:  1991-12-01

3.  Localization of an alpha-amanitin resistance mutation in the gene encoding the largest subunit of mouse RNA polymerase II.

Authors:  M S Bartolomei; J L Corden
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  Clustered alpha-amanitin resistance mutations in mouse.

Authors:  M S Bartolomei; J L Corden
Journal:  Mol Gen Genet       Date:  1995-03-20

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  CPD damage recognition by transcribing RNA polymerase II.

Authors:  Florian Brueckner; Ulrich Hennecke; Thomas Carell; Patrick Cramer
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

7.  A beta-turn in alpha-amanitin is the most important structural feature for binding to RNA polymerase II and three monoclonal antibodies.

Authors:  K Baumann; G Zanotti; H Faulstich
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

8.  PHENIX: An R package to estimate a size-controlled phenotypic integration index.

Authors:  Rubén Torices; A Jesús Muñoz-Pajares
Journal:  Appl Plant Sci       Date:  2015-05-06       Impact factor: 1.936

9.  Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis.

Authors:  Wilson Wong; Xiao-Chen Bai; Brad E Sleebs; Tony Triglia; Alan Brown; Jennifer K Thompson; Katherine E Jackson; Eric Hanssen; Danushka S Marapana; Israel S Fernandez; Stuart A Ralph; Alan F Cowman; Sjors H W Scheres; Jake Baum
Journal:  Nat Microbiol       Date:  2017-03-13       Impact factor: 17.745

10.  TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action.

Authors:  Yuan Gao; Erhu Cao; David Julius; Yifan Cheng
Journal:  Nature       Date:  2016-05-18       Impact factor: 49.962

View more
  8 in total

1.  3.1 Å structure of yeast RNA polymerase II elongation complex stalled at a cyclobutane pyrimidine dimer lesion solved using streptavidin affinity grids.

Authors:  Indrajit Lahiri; Jun Xu; Bong Gyoon Han; Juntaek Oh; Dong Wang; Frank DiMaio; Andres E Leschziner
Journal:  J Struct Biol       Date:  2019-06-11       Impact factor: 2.867

2.  The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.

Authors:  Alan C Kessler; Richard J Maraia
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

3.  Spatial organization of transcribed eukaryotic genes.

Authors:  Johannes Ribisel; Simon Ullrich; Susanne Leidescher; Yana Feodorova; Erica Hildebrand; Alexandra Galitsyna; Sebastian Bultmann; Stephanie Link; Katharina Thanisch; Christopher Mulholland; Job Dekker; Heinrich Leonhardt; Leonid Mirny; Irina Solovei
Journal:  Nat Cell Biol       Date:  2022-02-17       Impact factor: 28.213

Review 4.  Mechanism and treatment of α-amanitin poisoning.

Authors:  Jinfang Xue; Xiran Lou; Deyuan Ning; Ruifei Shao; Guobing Chen
Journal:  Arch Toxicol       Date:  2022-10-21       Impact factor: 6.168

5.  Structure of complete Pol II-DSIF-PAF-SPT6 transcription complex reveals RTF1 allosteric activation.

Authors:  Seychelle M Vos; Lucas Farnung; Andreas Linden; Henning Urlaub; Patrick Cramer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

6.  Nucleotide Loading Modes of Human RNA Polymerase II as Deciphered by Molecular Simulations.

Authors:  Nicolas E J Génin; Robert O J Weinzierl
Journal:  Biomolecules       Date:  2020-09-07

7.  Meeting key synthetic challenges in amanitin synthesis with a new cytotoxic analog: 5'-hydroxy-6'-deoxy-amanitin.

Authors:  Alla Pryyma; Kaveh Matinkhoo; Antonio A W L Wong; David M Perrin
Journal:  Chem Sci       Date:  2020-10-15       Impact factor: 9.825

8.  Identification of ncRNA-Mediated Functions of Nucleus-Localized miR-320 in Cardiomyocytes.

Authors:  Huaping Li; Jiabing Zhan; Yanru Zhao; Jiahui Fan; Shuai Yuan; Zhongwei Yin; Beibei Dai; Chen Chen; Dao Wen Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.